SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

13 Feb 2023 Evaluate
The sales declined to Rs. 1726.88 millions for the December 2022 quarter as compared to Rs. 2002.24 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended December 2022 rise to 27.57% to Rs. 157.93  millions  compared to R. 123.80 millions in corresponding previous quarter.Operating profit for the quarter ended December 2022 rose to 385.33 millions as compared to 303.76 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1726.88 2002.24 -13.75 5712.77 4841.19 18.00 6855.08 6000.48 14.24
Other Income 110.17 72.48 52.00 358.50 120.89 196.55 187.04 164.43 13.75
PBIDT 385.33 303.76 26.85 1208.58 573.49 110.74 876.78 673.40 30.20
Interest 116.52 64.49 80.68 435.62 235.41 85.05 249.19 325.37 -23.41
PBDT 268.81 239.27 12.35 772.96 338.08 128.63 627.59 343.00 82.97
Depreciation 75.37 67.22 12.12 221.04 197.85 11.72 266.83 192.83 38.38
PBT 193.44 172.05 12.43 551.92 140.23 293.58 360.76 150.17 140.23
TAX 35.51 48.25 -26.40 154.40 39.00 295.90 102.07 67.37 51.51
Deferred Tax -1.23 16.83 -107.31 45.50 13.39 239.81 38.09 39.58 -3.76
PAT 157.93 123.80 27.57 397.52 101.23 292.69 258.69 82.80 212.43
Equity 157.08 127.63 23.07 157.08 127.63 23.07 156.98 127.50 23.12
PBIDTM(%) 22.31 15.17 47.08 21.16 11.85 78.59 12.79 11.22 13.97

Camlin Fine Sciences Share Price

132.35 0.50 (0.38%)
05-May-2026 12:26 View Price Chart
Peers
Company Name CMP
BASF India 3640.75
Tata Chemicals 801.05
SRF 2528.40
Pidilite Inds. 1359.10
Deepak Nitrite 1765.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×